Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200010831> ?p ?o ?g. }
- W3200010831 endingPage "4726" @default.
- W3200010831 startingPage "4726" @default.
- W3200010831 abstract "Background: Uveal melanoma is the most commonly occurring primary intraocular malignancy in adults, and patients have a high risk of developing metastatic disease, mostly in the liver. Isolated hepatic perfusion (IHP) with melphalan is a liver-directed therapy for patients with liver metastases. Percutaneous hepatic perfusion (PHP), a minimally invasive technique, is available as well. PHP benefits from the fact that the procedure can be repeated and therefore possibly offers better survival. We conducted a systematic review and meta-analysis comparing both techniques. Methods: A systematic literature search was performed using the electronic databases of Scopus, MEDLINE, Web of Science, PubMed and Cochrane CENTRAL. A total of nine articles reporting on eight studies were included in the analysis. Individual survival data were extracted from each study. Results: The median overall survival (OS) was 17.1 months for IHP and 17.3 months for PHP. The median progression-free survival (PFS) was 7.2 months for IHP and 9.6 months for PHP. The median hepatic progression-free survival was 10 months for IHP and 9.5 months for PHP. The complication rate and 30-day mortality rate were 39.1% and 5.5% for IHP and 23.8% and 1.8% for PHP. Conclusion: There was no difference in OS or PFS between IHP and PHP for patients with uveal melanoma liver metastases, but patients have significantly less of a risk for complications and mortality following PHP." @default.
- W3200010831 created "2021-09-27" @default.
- W3200010831 creator A5014354451 @default.
- W3200010831 creator A5079236953 @default.
- W3200010831 creator A5085535416 @default.
- W3200010831 date "2021-09-21" @default.
- W3200010831 modified "2023-10-17" @default.
- W3200010831 title "Meta-Analysis of Isolated Hepatic Perfusion and Percutaneous Hepatic Perfusion as a Treatment for Uveal Melanoma Liver Metastases" @default.
- W3200010831 cites W1526940895 @default.
- W3200010831 cites W1573356710 @default.
- W3200010831 cites W1700205903 @default.
- W3200010831 cites W1965605266 @default.
- W3200010831 cites W1966468806 @default.
- W3200010831 cites W1970012109 @default.
- W3200010831 cites W1972240035 @default.
- W3200010831 cites W2005576578 @default.
- W3200010831 cites W2019607817 @default.
- W3200010831 cites W2020855013 @default.
- W3200010831 cites W2023903380 @default.
- W3200010831 cites W2032053038 @default.
- W3200010831 cites W2036828116 @default.
- W3200010831 cites W2045894281 @default.
- W3200010831 cites W2051472988 @default.
- W3200010831 cites W2055835855 @default.
- W3200010831 cites W2055908412 @default.
- W3200010831 cites W2059131316 @default.
- W3200010831 cites W2095582511 @default.
- W3200010831 cites W2096998881 @default.
- W3200010831 cites W2097066058 @default.
- W3200010831 cites W2097829977 @default.
- W3200010831 cites W2098859174 @default.
- W3200010831 cites W2106584438 @default.
- W3200010831 cites W2111656504 @default.
- W3200010831 cites W2131138289 @default.
- W3200010831 cites W2133681643 @default.
- W3200010831 cites W2139248078 @default.
- W3200010831 cites W2143878396 @default.
- W3200010831 cites W2151220178 @default.
- W3200010831 cites W2175338710 @default.
- W3200010831 cites W2259778421 @default.
- W3200010831 cites W2304494939 @default.
- W3200010831 cites W2312246970 @default.
- W3200010831 cites W2342748500 @default.
- W3200010831 cites W2419963939 @default.
- W3200010831 cites W2500083776 @default.
- W3200010831 cites W2512367333 @default.
- W3200010831 cites W2515516401 @default.
- W3200010831 cites W2516337088 @default.
- W3200010831 cites W2538994991 @default.
- W3200010831 cites W2571297294 @default.
- W3200010831 cites W2585730343 @default.
- W3200010831 cites W2590536177 @default.
- W3200010831 cites W2630584086 @default.
- W3200010831 cites W2650204451 @default.
- W3200010831 cites W2776106750 @default.
- W3200010831 cites W2902749870 @default.
- W3200010831 cites W2911436035 @default.
- W3200010831 cites W2929820659 @default.
- W3200010831 cites W2947554082 @default.
- W3200010831 cites W2947820344 @default.
- W3200010831 cites W2984462607 @default.
- W3200010831 cites W2992213357 @default.
- W3200010831 cites W3035850430 @default.
- W3200010831 cites W3047450798 @default.
- W3200010831 cites W3082097541 @default.
- W3200010831 cites W3083849833 @default.
- W3200010831 cites W3092438256 @default.
- W3200010831 cites W3113597973 @default.
- W3200010831 cites W3127932748 @default.
- W3200010831 cites W3150351010 @default.
- W3200010831 cites W3151104752 @default.
- W3200010831 cites W3164310383 @default.
- W3200010831 cites W3196177384 @default.
- W3200010831 cites W65135050 @default.
- W3200010831 cites W1995539154 @default.
- W3200010831 doi "https://doi.org/10.3390/cancers13184726" @default.
- W3200010831 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8469397" @default.
- W3200010831 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34572953" @default.
- W3200010831 hasPublicationYear "2021" @default.
- W3200010831 type Work @default.
- W3200010831 sameAs 3200010831 @default.
- W3200010831 citedByCount "10" @default.
- W3200010831 countsByYear W32000108312021 @default.
- W3200010831 countsByYear W32000108312022 @default.
- W3200010831 countsByYear W32000108312023 @default.
- W3200010831 crossrefType "journal-article" @default.
- W3200010831 hasAuthorship W3200010831A5014354451 @default.
- W3200010831 hasAuthorship W3200010831A5079236953 @default.
- W3200010831 hasAuthorship W3200010831A5085535416 @default.
- W3200010831 hasBestOaLocation W32000108311 @default.
- W3200010831 hasConcept C126322002 @default.
- W3200010831 hasConcept C141071460 @default.
- W3200010831 hasConcept C146957229 @default.
- W3200010831 hasConcept C2776283816 @default.
- W3200010831 hasConcept C2776694085 @default.
- W3200010831 hasConcept C2777658100 @default.
- W3200010831 hasConcept C2778684742 @default.
- W3200010831 hasConcept C2779399171 @default.